BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Rosiglitazone
,
rs6983267
,
IGF1
,
cell-cell adhesion
,
Pseudomonas infection
,
Lymphocyte
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
dapt
Summary
General Info
Curated Studies
Most Correlated Studies
Prostate basal cells treated with a gamma-secretase inhibitor DAPT
Gliobastoma initiating cells (patient-derived) with RBPJ shRNA knockdown and treated with DAPT
Dental pulp cells treated with JAG1 and gamma secretase inhibitor DAPT
Squamous cell carcinoma of mouth HSC-4 cells treated with gamma secretase inhibitor DAPT
T-ALL Jurkat cells treated with RBPJ inhibitor-1, DAPT or CB-103 or with RBPJ siRNA knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
Risk prediction of bleeding and MACCE by PRECISE-DAPT score post-PCI.
Notch signaling pathway inhibitor DAPT improves alcohol-induced neuronal differentiation impairment …
Comparison of De-escalation of DAPT Intensity or Duration in East Asian and Western Patients with AC…
Estimation of DAPT Study Treatment Effects in Contemporary Clinical Practice: Findings From the EXTE…
DAPT Attenuates Cadmium-Induced Toxicity in Mice by Inhibiting Inflammation and the Notch/HES-1 Sign…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
EVOLVE Short DAPT Study
Repetitive Assessement of PRECISE-DAPT Score
Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regime…
The Dual Antiplatelet Therapy Study (DAPT Study)
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ